EXOMEDICINE INSTITUTE AWARDS $300,000 GRANT TO MOREHEAD STATE UNIVERSITY FOR SPACE-BASED MEDICAL RESEARCH
MSU’s Center will develop experiments to be conducted in space to help patients on Earth
MOREHEAD, KY – Today the Exomedicine Institute, a Kentucky based nonprofit that fosters medical research and development in the microgravity environment of space, awarded a $300,000 grant to Morehead State University for the creation of the Exomedicine Center for Applied Technology.
The first of its kind Exomedicine Center for Applied Technology will bring together scientists, researchers, entrepreneurs and students to design, develop and execute experiments which will then have the opportunity to be carried out aboard the International Space Station (ISS).
“Morehead is proud to be at the forefront of space-based medical research,” said Dr. Wayne Andrews, Morehead State University president. “The Exomedicine Center for Applied Technology will allow our students and professors to be a part of cutting-edge experimentation that has the potential to change lives and the future of life science research as we know it.”
“I was honored to include language in the 2016 budget bill that made this appropriation possible, and worked closely with Morehead State University and the Kentucky Science and Technology Corporation on this important investment,” said state Rep. Rocky Adkins. “This type of innovation provides us with the potential to find cures for terrible diseases like cancer, while also creating the type of 21st century jobs our people need and deserve. It’s another important step toward rebuilding and diversifying the economy of Eastern Kentucky.”
This unique opportunity is made possible via the Center’s partnership with the Exomedicine Institute, located in Lexington, which maintains infrastructure aboard the ISS to conduct such experiments. Findings from these experiments will be used to improve medical treatments for patients on Earth.
“The microgravity environment of space represents a vast, untapped laboratory for exploring new medical solutions. Our investment in Morehead represents an important step toward mainstreaming this exciting new field,” said Dr. Kyle Keeney, executive director of the Exomedicine Institute. “Researchers are already discovering valuable new information about cancer, pharmaceuticals and even tissue regeneration from experiments on the International Space Station.”
To learn more about the Exomedicine Institute and space-based medical research, please visit www.exomedicine.com.